NBTX Stock Analysis: Buy, Sell, or Hold?
NBTX - Nanobiotix S.A. American Depositary Shares
$21.00
-0.89 (-4.07%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Apr 28, 2026
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NBTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NBTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.34
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$15.11
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $21.00, which is considered slightly low relative to its 30-day fair value range of $20.56 to $22.52. The stock's valuation (Forward PE: 31.5) is in line with its historical norms (30.4). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $19.80, while resistance sits at $22.74. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: NBTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $19.80, while resistance sits at $22.74. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: NBTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$20.56 -
$22.52
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- NEUTRAL: Near Wall St target ($23.55)
- NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$20.56 -
$22.52
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$19.80
Resistance Level
$22.74
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
31.50
Wall Street Target
$23.55
(+7.6%)
Revenue Growth (YoY)
186.8%
Valuation Premium vs History
+1.2% premium
PE vs Historical
31.5 vs 30.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.2%
(market-implied from PE analysis)
1-Year Target
$22.15
(+1%)
2-Year Target
$22.42
(+2%)
3-Year Target
$22.69
(+4%)
3-Yr Target (if PE normalizes)
(PE: 32→30)
PE COMPRESSION
$21.89
(0%)
Earnings growth offset by PE compression
Last updated: January 30, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
Advanced NBTX Option Strategies
Professional options setups generated by AI based on today's NBTX price and gamma walls.
